Disease | Target Count | P-value |
---|---|---|
osteosarcoma | 7933 | 0.00132237409948615 |
group 3 medulloblastoma | 2254 | 0.00230674485719404 |
Disease | Target Count | Z-score | Confidence |
---|---|---|---|
Schizophrenia | 503 | 0.0 | 2.0 |
Disease | log2 FC | p |
---|---|---|
osteosarcoma | -1.697 | 0.001 |
group 3 medulloblastoma | 2.400 | 0.002 |
PMID | Text |
---|---|
21682944 | This study revealed CEACAM21 as novel schizophrenia candidate genes in the Jewish population |
MGPPSACPHRECIPWQGLLLTASLLTFWNAPTTAWLFIASAPFEVAEGENVHLSVVYLPENLYSYGWYKG 1 - 70 KTVEPNQLIAAYVIDTHVRTPGPAYSGRETISPSGDLHFQNVTLEDTGYYTLQVTYRNSQIEQASHHLRV 71 - 140 YESVAQPSIQASSTTVTEKGSVVLTCHTNNTGTSFQWIFNNQRLQVTKRMKLSWFNHMLTIDPIRQEDAG 141 - 210 EYQCEVSNPVSSNRSDPLKLTVKSDDNTLGILIGVLVGSLLVAALVCFLLLRKTGRASDQSDFREQQPPA 211 - 280 STPGHGPSDSSIS 281 - 293 //
PMID | Year | Title |
---|---|---|
23065704 | 2013 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. |
21682944 | 2012 | DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. |
15489334 | 2004 | The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |
15057824 | 2004 | The DNA sequence and biology of human chromosome 19. |
14702039 | 2004 | Complete sequencing and characterization of 21,243 full-length human cDNAs. |
12975309 | 2003 | The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. |
12477932 | 2002 | Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |